Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#lamotrigine ×

Regulatory Updates

Sep 10, 2026•1 min read

FDA Approves Chartwell Molecular Lamotrigine Tablet ANDA077783

FDA has approved ANDA 077783 for oral lamotrigine tablets (25‑200 mg) submitted by Chartwell Molecular, with multiple labeling submissions cleared.